1590
Y. Zhou et al.
Letter
Synlett
References and Notes
pyrrole-2-carboxylic acid (9 mg, 0.08 mmol), NaI (15 mg, 0.1
mmol), and K2CO3 (138 mg, 1.0 mmol), evacuated, and back-
filled with argon. DMSO (1.5 mL) was successively added. The
reaction mixture was stirred at 25 °C for 24–30 h before oxygen
was introduced. After the reaction mixture was stirred at 25 °C
for 3–5 h, it was extracted with EtOAc. The combined organic
phase was washed with brine and dried over Na2SO4. After con-
centration in vacuo, the residue was purified by column chro-
matography on silica gel to provide 9.
(1) Hay, M. P.; Hicks, K. O.; Pchalek, K.; Lee, H. H.; Blaser, A.; Pruijn,
F. B.; Anderson, R. F.; Shinde, S. S.; Wilson, W. R.; Denny, W. A. J.
Med. Chem. 2008, 51, 6853.
(2) Noronha, G.; Barrett, K.; Cao, J.; Dneprovskaia, E.; Fine, R.; Gong,
X.; Gritzen, C.; Hood, J.; Kang, X.; Klebansky, B.; Li, G.; Lose, D.;
Mark, C.; McPherson, A.; Palanki, M.; Pathak, V.; Renick, J.; Soll,
R.; Splittgerber, U.; Wrasidlo, W.; Zeng, B.; Zhao, N.; Zhou, Y.
Bioorg. Med. Chem. Lett. 2006, 16, 5546.
Compound 9a: 1H NMR (500 MHz, CDCl3): δ = 9.54 (s, 1 H), 8.70
(dd, J = 8.5, 1.1 Hz, 1 H), 7.74 (dd, J = 8.2, 1.5 Hz, 1 H), 7.54 (ddd,
J = 8.6, 7.5, 1.5 Hz, 1 H), 7.09 (ddd, J = 8.4, 7.3, 1.3 Hz, 2 H), 2.41
(t, J = 7.4 Hz, 2 H) 1.80–1.72 (m, 2 H), 1.65 (s, 9 H), 1.00 (t, J = 7.4
Hz, 3 H). 13C NMR (125 MHz, CDCl3): δ = 171.66, 160.23, 138.25,
138.05, 136.01, 123.11, 120.55, 119.36, 84.97, 40.16, 27.85 (3C),
18.75, 13.68. ESI-MS: m/z = 314.2 [M + Na]+. ESI-HRMS:m/z
calcd for C15H22N3O3+ [M + H]+: 292.1656; found: 292.1653.
Compound 9k: 1H NMR (500 MHz, CDCl3): δ = 11.10 (s, 1 H),
8.83 (dd, J = 8.5, 1.1 Hz, 1 H), 7.95 (dd, J = 8.1, 1.6 Hz, 1 H), 7.71
(dd, J = 3.8, 1.1 Hz, 1 H), 7.62 (dd, J = 7.3, 1.4 Hz, 1 H), 7.59 (dd,
J = 5.0, 1.0 Hz, 1 H), 7.22 (ddd, J = 8.3, 7.4, 1.2 Hz, 1 H), 7.14 (dd,
J = 5.0, 3.8 Hz, 1 H), 1.71 (s, 9 H). 13C NMR (125 MHz, CDCl3): δ =
160.30, 159.14, 139.74, 138.01, 136.45, 136.30, 131.71, 128.83,
127.88, 125.30, 123.50, 120.31, 84.95, 27.88 (3 C). ESI-MS: m/z =
354.2 [M + Na]+. ESI-HRMS:m/z calcd for C16H18N3O3S+ [M + H]+:
332.1063; found: 332.1061.
(3) Boyle, R. G.; Travers, S. WO 2008015429, 2008.
(4) Zeller, M. WO 9838161, 1998.
(5) Lee, J.; Lee, S.; Seo, H.; Kim, M.; Kang, S.; Kim, J.; Lee, S.; Jung,
M.; Son, E.; Lee, J.; Song, K.; Kim, M. WO 2010147430, 2010.
(6) Settimo, F. D.; Primofiore, G.; Taliani, S.; Marini, A. M.; La Motta,
C.; Simorini, F.; Salerno, S.; Sergianni, V.; Tuccinardi, T.;
Martinelli, A.; Cosimelli, B.; Greco, G.; Novellino, E.; Ciampi, O.;
Trincavelli, M. L.; Martini, C. J. Med. Chem. 2007, 50, 5676.
(7) Fleck, F.; Balzer, H.; Aebli, H. FR 1411433, 1965.
(8) Selby, T. US 5389600, 1995.
(9) Leverenz, K.; Schuendehuette, K. DE 2241259, 1974.
(10) (a) Riccardo, C.; Alessandro, B.; Fabio, S. J. Heterocycl. Chem.
1979, 16, 1005. (b) Reich, M.; Fabio, P.; Lee, V.; Kuck, N.; Testa, R.
J. Med. Chem. 1989, 32, 2474.
(11) Bass, J. Y.; Caravella, J. A.; Chen, L.; Creech, K. L.; Deaton, D. N.;
Madauss, K. P.; Marr, H. B.; McFadyen, R. B.; Miller, A. B.; Mills,
W. Y.; Navas, F. III.; Parks, D. J.; Smalley, T. L. Jr.; Spearing, P. K.;
Todd, D.; Williams, S. P.; Wisely, G. B. Bioorg. Med. Chem. Lett.
2011, 21, 1206.
(12) Guo, H.; Liu, J.; Wang, X.; Huang, G. Synlett 2012, 23, 903.
(13) (a) Chen, Y.; Ma, D. Org. Lett. 2006, 8, 6115. (b) Chen, Y.; Xie, X.;
Ma, D. J. Org. Chem. 2007, 72, 9329. (c) Lu, B.; Wang, B.; Zhang,
Y.; Ma, D. J. Org. Chem. 2007, 72, 5337. (d) Zou, B.; Yuan, Q.; Ma,
D. Angew. Chem. Int. Ed. 2007, 46, 2598. (e) Ma, D.; Xie, S.; Xue,
P.; Zhang, X.; Dong, J.; Jiang, Y. Angew. Chem. Int. Ed. 2009, 48,
4222. (f) Ma, D.; Geng, Q.; Zhang, H.; Jiang, Y. Angew. Chem. Int.
Ed. 2010, 49, 1291. (g) Shi, L.; Liu, X.; Zhang, H.; Jiang, Y.; Ma, D.
J. Org. Chem. 2011, 76, 4200. (h) Ma, D.; Lu, X.; Shi, L.; Zhang, H.;
Jiang, Y.; Liu, X. Angew. Chem. Int. Ed. 2011, 50, 1118. (i) Xu, L.;
Jiang, Y.; Ma, D. Org. Lett. 2012, 14, 1150.
(18) Typical Procedure for the Prepration of 10
To a solution of 9 (0.2 mmol) in CH2Cl2 (2.0 mL) was added TFA
(0.5 mL). The solution was stirred at r.t. for 2 h before aq
NaHCO3 (5 mL) was added. The mixture was extracted with
CH2Cl2. The organic phase was dried over Na2SO4, filtered, and
concentrated under vacuum. The residue was purified by
column chromatography on silica gel to provide 10.
Compound 10a: 1H NMR (400 MHz, CDCl3): δ = 8.49 (d, J = 8.4
Hz, 1 H), 7.99 (d, J = 7.9 Hz, 1 H), 7.96–7.90 (m, 1 H), 7.83–7.77
(m, 1 H), 3.35 (t, J = 9.6 Hz, 2 H), 2.08–1.97 (m, 2 H), 1.06 (t, J =
7.4 Hz, 3 H). 13C NMR (125 MHz, CDCl3): δ = 166.45, 146.18,
140.85, 135.25, 129.82, 129.53, 128.51, 39.69, 22.28, 13.92. ESI-
+
MS: m/z = 174.1 [M + H]+. ESI-HRMS:m/z calcd for C10H12N3
[M + H]+: 174.1026; found: 174.1025.
Compound 10h: 1H NMR (500 MHz, CDCl3): δ = 8.46 (dd, J = 8.4,
0.7 Hz, 1 H), 8.35 (dd, J = 3.7, 1.1 Hz, 1 H), 8.02–7.97 (m, 1 H),
7.92 (ddd, J = 8.4, 6.8, 1.3 Hz, 1 H), 7.76 (ddd, J = 8.2, 6.8, 1.3 Hz,
1 H), 7.61 (dd, J = 5.0, 1.1 Hz, 1 H), 7.24 (dd, J = 4.9, 3.7 Hz, 1 H).
13C NMR (125 MHz, CDCl3): δ = 157.36, 146.00, 140.87, 140.72,
135.72, 131.31, 130.61, 129.75, 129.70, 128.65, 128.61. ESI-MS:
m/z = 214.1 [M + H]+. ESI-HRMS:m/z calcd for C11H8N3S+ [M +
H]+: 214.0433; found: 214.0432.
(14) For copper-catalyzed oxidation of aryl hydrazines to azo com-
pounds, see: Zhang, C.; Jiao, N. Angew. Chem. Int. Ed. 2010, 49,
6174.
(15) (a) Jiang, L.; Lu, X.; Zhang, H.; Jiang, Y.; Ma, D. J. Org. Chem. 2009,
74, 4542. (b) Xiong, X.; Jiang, Y.; Ma, D. Org. Lett. 2012, 14, 2552.
(16) (a) Wolter, M.; Klapars, A.; Buchwald, S. L. Org. Lett. 2001, 3,
3803. (b) Lam, M. S.; Lee, H. W.; Chan, A. C.; Kwong, F. Y. Tetra-
hedron Lett. 2008, 49, 6192.
(17) General Procedure for the Preparation of 9
A Schlenk tube was charged with iodide 7 (0.5 mmol), N-Boc
hydrazine (70 mg, 0.53 mmol), CuI (5 mg, 0.025 mmol), 1H-
© Georg Thieme Verlag Stuttgart · New York — Synlett 2015, 26, 1586–1590